ONCO Nilai Total Aset Perusahaan Onconetix Inc

Onconetix, Inc. (ONCO) develops solutions to combat cancer and male health issues, leveraging patent protection for the global rollout of high-margin products. The business remains independent of macroeconomic trends, relying on the sale of tests and therapies in Europe and the US. The market dynamics of total assets reflected in the price action stand at 17.78, supported by the expansion of Entadfi, the development of diagnostic systems, and new B2B deals.

ONCO (Onconetix, Inc.) riwayat Total Aset Perusahaan saka 21.02.2024 nganti 31.10.2026

Total assets represent the aggregate volume of business resources, calculated reverse-engineered via ROA to identify the impact of cost inflation on the balance sheet. Analyzing this valuation of total asset value allows for tracking the expansion of the Onconetix, Inc. (ONCO) base, where resource growth is critical for the capitalization of intellectual property and the subsequent global scaling of high-margin oncology therapy drugs.